Verdinexor

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVerdinexor
Drug Alias Name凡迪尼索Verdinexorum维迪奈索KPT-335ATG-527 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionExportin-1 protein inhibitors
TargetsExportin-1 protein
Therapy Area/IndicationsVirus DiseasesLupus Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKaryopharm Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKaryopharm Therapeutics IncAntengene Corporation Co Ltd
Inactive CompaniesN/A
Active IndicationsVirus DiseasesLupus Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A